EUTHYROX Drug Patent Profile
✉ Email this page to a colleague
When do Euthyrox patents expire, and when can generic versions of Euthyrox launch?
Euthyrox is a drug marketed by Provell and is included in one NDA.
The generic ingredient in EUTHYROX is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Euthyrox
A generic version of EUTHYROX was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for EUTHYROX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 8 |
Patent Applications: | 2,726 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EUTHYROX |
What excipients (inactive ingredients) are in EUTHYROX? | EUTHYROX excipients list |
DailyMed Link: | EUTHYROX at DailyMed |
Recent Clinical Trials for EUTHYROX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 |
Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Zhejiang Provincial Hospital of TCM | Phase 4 |
Pharmacology for EUTHYROX
Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for EUTHYROX
US Patents and Regulatory Information for EUTHYROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Provell | EUTHYROX | levothyroxine sodium | TABLET;ORAL | 021292-001 | May 31, 2002 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Provell | EUTHYROX | levothyroxine sodium | TABLET;ORAL | 021292-007 | May 31, 2002 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Provell | EUTHYROX | levothyroxine sodium | TABLET;ORAL | 021292-004 | May 31, 2002 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Provell | EUTHYROX | levothyroxine sodium | TABLET;ORAL | 021292-012 | May 31, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Provell | EUTHYROX | levothyroxine sodium | TABLET;ORAL | 021292-008 | May 31, 2002 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |